(Q37038825)

17 August 2017

Targeted nanomaterials for radiotherapy (English)

1 reference

Adaptive radiation therapy

17 August 2017

0 references

0 references

Freddy E Escorcia

1

0 references

author name string

Michael R McDevitt

series ordinal

2

1 reference

PubMed ID

18095847

17 August 2017

Carlos H Villa

series ordinal

3

1 reference

PubMed ID

18095847

17 August 2017

David A Scheinberg

series ordinal

4

1 reference

17 August 2017

1 December 2007

1 reference

17 August 2017

1 reference

17 August 2017

2

1 reference

17 August 2017

6

1 reference

17 August 2017

805-815

1 reference

17 August 2017

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Projections of global mortality and burden of disease from 2002 to 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Exploiting the enhanced permeability and retention effect for tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

VEGF-targeted cancer therapy strategies: current progress, hurdles and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

p53 target gene SMAR1 is dysregulated in breast cancer: its role in cancer cell migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Radiolabeled high affinity peptidomimetic antagonist selectively targets alpha(v)beta(3) receptor-positive tumor in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Combinatorial antibody libraries from cancer patients yield ligand-mimetic Arg-Gly-Asp-containing immunoglobulins that inhibit breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Denileukin diftitox: a concise clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Technological advances in radioimmunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Tumor therapy with targeted atomic nanogenerators

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Antibody-based treatment of acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

In vitro and preclinical targeted alpha therapy of human prostate cancer with Bi-213 labeled J591 antibody against the prostate specific membrane antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Pharmacokinetic characterization in xenografted mice of a series of first-generation mimics for HLA-DR antibody, Lym-1, as carrier molecules to image and treat lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Selective laser nano-thermolysis of human leukemia cells with microbubbles generated around clusters of gold nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Water-soluble gadofullerenes: toward high-relaxivity, pH-responsive MRI contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

A fullerene-paclitaxel chemotherapeutic: synthesis, characterization, and study of biological activity in tissue culture

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Fullerene (C60) immunoconjugates: interaction of water-soluble C60 derivatives with the murine anti-gp240 melanoma antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Comparative pulmonary toxicity assessments of C60 water suspensions in rats: few differences in fullerene toxicity in vivo in contrast to in vitro profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

In vivo studies of fullerene-based materials using endohedral metallofullerene radiotracers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Biological interactions of functionalized single-wall carbon nanotubes in human epidermal keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Impact of carbon nanotube exposure, dosage and aggregation on smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Tumor targeting with antibody-functionalized, radiolabeled carbon nanotubes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Biodistribution of functionalized multiwall carbon nanotubes in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

In vivo biodistribution of dendrimers and dendrimer nanocomposites -- implications for cancer imaging and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Dendrimer biocompatibility and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Synthesis and characterization of PAMAM dendrimer-based multifunctional nanodevices for targeting alphavbeta3 integrins.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Long-circulating gadolinium-encapsulated liposomes for potential application in tumor neutron capture therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Boron neutron capture therapy of cancer: current status and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Monoclonal antibody 2C5-modified doxorubicin-loaded liposomes with significantly enhanced therapeutic activity against intracranial human brain U-87 MG tumor xenografts in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Emerging implications of nanotechnology on cancer diagnostics and therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

The effect of paclitaxel-loaded nanoparticles with radiation on hypoxic MCF-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Polymer conjugates as anticancer nanomedicines

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Mitigation of radiation nephropathy after internal alpha-particle irradiation of kidneys

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.2.6.805

21 January 2018

Identifiers

DOI

10.2217/17435889.2.6.805

1 reference

17 August 2017

1 reference

PubMed ID

18095847